Land: Portugal
Språk: engelska
Källa: HMA (Heads of Medicines Agencies)
hyaluronic acid 10 mg/ml
Bayer Vital GmbH
QM09AX01
Solution for injection
hyaluronic acid
Horses Food
2010-12-20
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Hyonate 10 mg / ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2.1 ACTIVE SUBSTANCE Hyaluronic acid (sodium) 18, 9 mg 2.2 EXCIPIENTS For full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horse 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of non-infectious synovitis of fetlock, carpal and tarsal joints 4.3 CONTRAINDICATIONS Abnormal sensitivity to exogene supply of sodium hyaluronate 4.4 SPECIAL WARNINGS None 4.5 SPECIAL PRECAUTIONS FOR USE 4.5.1 SPECIAL PRECAUTIONS FOR USE IN ANIMALS Strict aseptic technique should be observed when injecting the veterinary medicinal product. As with any intra-articular procedure, proper injection site disinfection and animal restraint are very important. Excess synovial fluid should be aseptically removed prior to injection. Care should be taken not to scratch the cartilage surface with the point of the injection needle. For best results, the horse should be given three days stable rest after intra-articular treatment before gradually resuming normal activity. 4.5.2 SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to hyaluronic acid should avoid contact with the veterinary medicinal product. 4.6 ADVERS Läs hela dokumentet